PHIBRO ANIMAL HEALTH CORP-A (PAHC)
US71742Q1067 - Common Stock
ChartMill assigns a Buy % Consensus number of 42% to PAHC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.97. This target is -17.56% below the current price.
PAHC was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about PAHC.
In the previous month the buy percentage consensus was at a similar level.
PAHC was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-09 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-09-01 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-08-31 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-29 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-07-27 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-05-04 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-02-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-12-21 | Roth Capital | Initiate | Buy |
| 2022-11-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-09-16 | Barclays | Maintains | Underweight |
| 2022-08-26 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-25 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2022-01-10 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2021-11-18 | Morgan Stanley | Initiate | Equal-Weight |
| 2021-07-07 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2021-05-13 | Morgan Stanley | Maintains | Underweight |